LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
27 funds hold it · 1 straight earnings beat
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 3, 2026
Period ending
Sep 30, 2026
Earnings per share
$2.10 expected
Estimates as of Nov 9, 2026
EPS expected
$2.32 to $2.56
Revenue expected
7 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 3, 2026 | $2.19est. $2.10 | +4.46%beat | $994.0MSEC filing | -0.7%from $1.00B |
| Jun 30, 2026Reported Aug 3, 2026 | $1.95est. $2.02 | -3.39%miss | $981.0MSEC filing | +4.9%from $935.0M |
| Mar 31, 2026Reported May 4, 2026 | $1.58est. $1.48 | +6.76%beat | $936.0MSEC filing | +9.6%from $854.0M |
| Dec 31, 2025Reported Feb 23, 2026 | $1.98est. $1.93 | +2.68%beat | $1.01BAlpha Vantage | +115.6%from $467.6M |
| Sep 30, 2025Reported Nov 3, 2025 | $1.94est. $1.51 | +28.48%beat | $1.00BSEC filing | +127.0%from $441.0M |
| Jun 30, 2025Reported Aug 4, 2025 | $1.49est. $1.28 | +16.41%beat | $935.0MSEC filing | +122.1%from $421.0M |
| Mar 31, 2025Reported May 5, 2025 | -$3.35est. $0.86 | -$4.21miss | $854.0MSEC filing | +117.7%from $392.3M |
| Dec 31, 2024Reported Feb 24, 2025 | $1.70est. $1.82 | -6.59%miss | $467.6MAlpha Vantage | +5.2%from $444.6M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.01B | $936.0M | $981.0M | $994.0M |
| Cost of what it sold | $659.9M | $607.0M | $622.0M | $641.0M |
| Gross profit | $348.1M | $329.0M | $359.0M | $353.0M |
| What it spent | ||||
| Research and development | $7.2M | — | — | — |
| Sales and admin | $268.6M | $261.0M | $313.0M | $253.0M |
| Total operating expenses | $275.8M | $261.0M | $313.0M | $253.0M |
| What was left | ||||
| Operating profit | $72.3M | $68.0M | $46.0M | $100.0M |
| Interest on debt | $12.0M | $10.0M | $13.0M | $13.0M |
| Profit before tax | $59.0M | $60.0M | $35.0M | $88.0M |
| Tax | $5.9M | $15.0M | $7.0M | $18.0M |
| Net profit | $53.1M | $45.0M | $28.0M | $70.0M |
| EBITDA | $138.7M | $138.0M | $114.0M | $164.0M |
This stock is trending upward, and looks overbought after a fast run-up.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
JBT Marel Stock What Raised Guidance And Buybacks Mean
BullishNov 5What JBT Marel (JBTM) Said on Its Q3 Earnings Call
Leans bullishNov 4JBT Marel Corporation Files Third Quarter 2026 Form 10-Q
NeutralNov 3JBT Marel Corporation Targets 20% Adjusted EBITDA Margin in 2028
BullishNov 3Earnings call transcript: JBT Marel tops EPS in Q3 2026 as shares rise
BullishNov 3Poultry growth lifts JBT Marel Protein Solutions revenue 6%
NeutralNov 3JBT Marel Corporation (JBTM) Raises Buyback Authorization to $700M
BullishNov 3JBT Marel Corporation Reports Third Quarter 2026 Results and Announces Increased Share Repurchase Authorization
BullishNov 312 macro signals shaping JBTM right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
